Medpace Holdings (MEDP) EPS (Basic) (2015 - 2026)
Medpace Holdings' (MEDP) quarterly EPS (Basic) came in at $4.31 in Q2 2026, up 36.5% on a YoY basis from $3.16 in Q2 2025, and down 1.08% quarter-over-quarter from $4.35 in Q1 2026.
Powered by 
Analysis
Medpace Holdings (MEDP) EPS (Basic) (2015 - 2026) Analysis & Trends
Medpace Holdings (MEDP) has reported EPS (Basic) for 12 consecutive years, with $4.31 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EPS (Basic) rose 36.5% year-over-year to $4.31; the trailing twelve-month figure through Jun 2026 stood at $17.45 (up 19.28% YoY), and the FY2025 full-year result was $15.64, up 19.72% from the prior year.
- EPS (Basic) fell to $4.31 in Q2 2026 per MEDP's latest filing, from $4.35 in the prior quarter.
- Across five years, EPS (Basic) topped out at $4.68 in Q4 2025 and bottomed at $1.52 in Q2 2022.
- Historically, EPS (Basic) has averaged $3.0 across 5 years, with a median of $2.98 in 2024.
- The sharpest annual moves came in 2022 and 2023: EPS (Basic) soared 57.0% in 2022, then rose 8.18% in 2023.
- Over 5 years, EPS (Basic) stood at $2.12 in 2022, then increased by 20.2% to $2.55 in 2023, then surged by 48.32% to $3.78 in 2024, then advanced by 23.93% to $4.68 in 2025, then dropped by 8.05% to $4.31 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered $4.31, $4.35, and $4.68 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 1.45 |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 4.31 |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 2.53 |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | -0.02 |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | -0.14 |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -0.75 |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -0.03 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -92.33 |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -0.52 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.31 |
| Mar 31, 2026 | 4.35 |
| Dec 31, 2025 | 4.68 |
| Sep 30, 2025 | 3.95 |
| Jun 30, 2025 | 3.16 |
| Mar 31, 2025 | 3.77 |
| Dec 31, 2024 | 3.78 |
| Sep 30, 2024 | 3.11 |
| Jun 30, 2024 | 2.85 |
| Mar 31, 2024 | 3.33 |
| Dec 31, 2023 | 2.55 |
| Sep 30, 2023 | 2.30 |
| Jun 30, 2023 | 2.00 |
| Mar 31, 2023 | 2.35 |
| Dec 31, 2022 | 2.12 |
| Sep 30, 2022 | 2.13 |
| Jun 30, 2022 | 1.52 |
| Mar 31, 2022 | 1.76 |
| Dec 31, 2021 | 1.40 |
| Sep 30, 2021 | 1.36 |